TW336224B - Compound useful as adhesion receptor antagonists, their preparation processes, and pharmaceutical compositions containing same - Google Patents

Compound useful as adhesion receptor antagonists, their preparation processes, and pharmaceutical compositions containing same

Info

Publication number
TW336224B
TW336224B TW083103856A TW83103856A TW336224B TW 336224 B TW336224 B TW 336224B TW 083103856 A TW083103856 A TW 083103856A TW 83103856 A TW83103856 A TW 83103856A TW 336224 B TW336224 B TW 336224B
Authority
TW
Taiwan
Prior art keywords
denotes
pharmaceutical compositions
compositions containing
receptor antagonists
compound useful
Prior art date
Application number
TW083103856A
Other languages
English (en)
Inventor
Peter Raddatz
Joachim Gante
Juraszyk Horst Dr
Wurziger Dr
Helmut Prucher
Sabine Bernotat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of TW336224B publication Critical patent/TW336224B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW083103856A 1993-05-01 1994-04-28 Compound useful as adhesion receptor antagonists, their preparation processes, and pharmaceutical compositions containing same TW336224B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4314378 1993-05-01
DE4405633A DE4405633A1 (de) 1993-05-01 1994-02-22 Adhäsionsrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
TW336224B true TW336224B (en) 1998-07-11

Family

ID=6486893

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103856A TW336224B (en) 1993-05-01 1994-04-28 Compound useful as adhesion receptor antagonists, their preparation processes, and pharmaceutical compositions containing same

Country Status (4)

Country Link
DE (2) DE4405633A1 (zh)
TW (1) TW336224B (zh)
UA (1) UA41280C2 (zh)
ZA (1) ZA942973B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE4439846A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten

Also Published As

Publication number Publication date
UA41280C2 (uk) 2001-09-17
ZA942973B (en) 1995-01-18
DE4405633A1 (de) 1994-11-03
DE59408441D1 (de) 1999-08-05

Similar Documents

Publication Publication Date Title
ZA9811576B (en) Anilide derivative, production and use thereof.
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
CA2328780A1 (en) Dihydropyrimidines
YU155290A (sh) Dusikove spojine
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
PL325312A1 (en) Methaguanidine, urea, thiourea or azacyclic derivatives of aminobenzoic acid as antagonists of integrin
MY114679A (en) Aroyl-piperidine derivatives
WO1998035951A3 (en) New aminopiperazine derivatives
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
ES8501383A1 (es) Procedimiento para preparar derivados de piperazina
EP0353955A3 (en) Novel compounds
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
EP0934932A4 (en) CHINOLINE DERIVATIVES AND PSYCHOTROPES MEDIUM
AU1414900A (en) Novel compound, polymer prepared from the compound, and composition comprising the polymer
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
CA2281918A1 (en) Oxazolidines as 5-ht2a-antagonists
WO1999062893A3 (de) Neue neurokininantagonisten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
EP0190356A4 (en) AMIDINE COMPOUNDS.
MY131762A (en) Pharmaceutical compounds
TW336224B (en) Compound useful as adhesion receptor antagonists, their preparation processes, and pharmaceutical compositions containing same
GB8829593D0 (en) Novel compounds
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
EP0251574A3 (en) Antifungal derivatives of n-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent